Drug Trial Radar · NCT01815736
Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Last checked: Nov 19, 2026Latest source record: Apr 13, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,443
Actual
Start
Mar 27, 2013
Primary completion
Mar 16, 2015
Study completion Apr 1, 2020
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Mar 21, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the non-inferiority of switching to a tenofovir alafenamide (TAF)-containing fixed dose combination (FDC) relative to maintaining tenofovir disoproxil fumarate (TDF)-containing combination regimens in virologically suppressed HIV-infected participants as determined by having HIV-1 RNA \< 50 copies/mL at Week 48.
Conditions
- HIV
- HIV Infections
Interventions
E/C/F/TAFDrug
150/150/200/10 mg FDC tablet administered orally once daily
E/C/F/TDFDrug
150/150/200/300 mg FDC tablet administered orally once daily
EFV/FTC/TDFDrug
600/200/300 mg FDC tablet administered orally once daily
RTVDrug
100 mg tablet administered orally once daily
ATVDrug
300 mg capsule administered orally once daily
FTC/TDFDrug
200/300 mg tablet administered orally once daily
COBIDrug
150 mg tablet administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With HIV-1 RNA < 50 Copies/mL at Week 48Time frame: Week 48
Locations
167 sites in 20 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Southwest Center for HIV/AIDS
Phoenix, Arizona
Spectrum Medical Group
Phoenix, Arizona
Health for Life Clinic PLLC
Little Rock, Arkansas
AHF Research Center
Beverly Hills, California
Michael Keith Wensley, MD, Inc., A Medical Corporation
Costa Mesa, California
Living Hope Clinical Foundation
Long Beach, California
Kaiser Permanente
Los Angeles, California
Jeffrey Goodman Special Care Clinic
Los Angeles, California
Peter J Ruane, MD, Inc
Los Angeles, California
Anthony Mills MD Inc
Los Angeles, California
Orange Coast Medical Group
Newport Beach, California
Alameda County Medical Center
Oakland, California
East Bay AIDS Center
Oakland, California
Stanford University
Palo Alto, California
University of California, Davis Medical Center
Sacramento, California
Kaiser Permanente Medical Group
Sacramento, California
La Playa Medical Group and Clinical Research
San Diego, California
Metropolis Medical Group
San Francisco, California
Kaiser Permanente Medical Center, Clinical Trials Unit
San Francisco, California
Kaiser Permanente Hospital
San Leandro, California
Apex Research LLC
Denver, Colorado
Greenwich Hospital
Greenwich, Connecticut
Yale University HIV Clinical Trials Program
New Haven, Connecticut
Dupont Circle Physicians Group
Washington D.C., District of Columbia
Whitman Walker Clinic
Washington D.C., District of Columbia
Capital Medical Associates, PC
Washington D.C., District of Columbia
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia
Therafirst Medical Center
Fort Lauderdale, Florida
Broward Health/Comprehensive Care Center
Fort Lauderdale, Florida
Gary J. Richmond,M.D.,P.A.
Fort Lauderdale, Florida
Midway Immunology and Research Center
Ft. Pierce, Florida
The Kinder Medical Group
Miami, Florida
Wohlfeiler, Piperato and Associates, LLC
Miami Beach, Florida
Orlando Immunology Center
Orlando, Florida
IDOCF/ Value Health MD, LLC
Orlando, Florida
University of South Florida HIV Clinical Research Unit / Hillsborough County Health Department
Tampa, Florida
Infectious Disease Research Institute Inc.
Tampa, Florida
St. Joseph's Comprehensive Research Institute
Tampa, Florida
AIDS Research Consortium of Atlanta
Atlanta, Georgia
Showing 40 of 167 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.